These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
922 related items for PubMed ID: 29243813
21. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR. Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391 [Abstract] [Full Text] [Related]
22. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Nolan SJ, Muller M, Tudur Smith C, Marson AG. Cochrane Database Syst Rev; 2013 May 31; (5):CD003615. PubMed ID: 23728645 [Abstract] [Full Text] [Related]
24. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial. Bonnett L, Smith CT, Smith D, Williamson P, Chadwick D, Marson AG. Lancet Neurol; 2012 Apr 31; 11(4):331-40. PubMed ID: 22377180 [Abstract] [Full Text] [Related]
25. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Quality Standards Subcommittee of the American Academy of Neurology, American Epilepsy Society. Neurology; 2004 Apr 27; 62(8):1261-73. PubMed ID: 15111660 [Abstract] [Full Text] [Related]
33. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study. Lai EC, Hsieh CY, Su CC, Yang YK, Huang CW, Lin SJ, Setoguchi S. Medicine (Baltimore); 2016 Aug 28; 95(35):e4481. PubMed ID: 27583857 [Abstract] [Full Text] [Related]
35. Gabapentin monotherapy for epilepsy: A review. Ziganshina LE, Abakumova T, Hoyle CHV. Int J Risk Saf Med; 2023 Aug 28; 34(3):243-286. PubMed ID: 37393439 [Abstract] [Full Text] [Related]
36. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Weston J, Greenhalgh J, Marson AG. Cochrane Database Syst Rev; 2015 Mar 04; (3):CD007286. PubMed ID: 25738821 [Abstract] [Full Text] [Related]
38. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Brigo F, Igwe SC, Lattanzi S. Cochrane Database Syst Rev; 2021 Jan 21; 1(1):CD003032. PubMed ID: 33475151 [Abstract] [Full Text] [Related]
39. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Brigo F, Igwe SC. Cochrane Database Syst Rev; 2017 Feb 14; 2(2):CD003032. PubMed ID: 28195639 [Abstract] [Full Text] [Related]